Effect of ethanol and DMSO in prophylaxis and treatment of COVID-19
Phase 3
Recruiting
- Conditions
- Covid-19.U07.1 COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20200727048217N1
- Lead Sponsor
- Shahroud University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 610
Inclusion Criteria
COVID-19 Patients
Close contact with COVID-19 Patinets
No current and previous infection with COVID-19 (for the preventive phase)
Exclusion Criteria
immigrant patients
pregnant patients
Anxiety and obsessive-compulsive disorder
Protocol noncompliance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mortality rate from Covid-19 patients. Timepoint: 2 weeks after intervention. Method of measurement: Survived or died according to the records.;- Recovery rate from Covid-19. Timepoint: 2 weeks after intervention. Method of measurement: qRT-PCR.;COVID-19 incidence in health employees. Timepoint: In intervention period. Method of measurement: qRT-PCR.
- Secondary Outcome Measures
Name Time Method General Health. Timepoint: At the start and the end of study. Method of measurement: Check list according to the Likert scale.;O2 Saturation. Timepoint: Daily, 8,14 and 21 O'clock. Method of measurement: Pals Oxy-meter.;Respiratory Rate. Timepoint: Daily, 8,14 and 21 O'clock. Method of measurement: Physical examination and berth count.;Temperature. Timepoint: Daily, 8,14 and 21 O'clock. Method of measurement: Thermometer.;Length of hospitalization. Timepoint: At the end of study. Method of measurement: Date of hospitalization and discharge stated in the patient file.;The need for intensive care and respiratory support. Timepoint: At the end of study. Method of measurement: Date of transfer to the ICU and discharge stated in the patient file.;Time of separation from the ventilator. Timepoint: At the end of study. Method of measurement: Date stated in the patient file.;Lymphocyte. Timepoint: At the beginning and end of the study. Method of measurement: Cell counter.